The results demonstrated that KRT5, UGT2B4, MRC1, CD209, and KLRB1 were significantly downregulated in HR+ breast cancer compared to normal breast tissue, whereas BIRC3 and FABP7 showed no significant differences in expression between the two groups (Figure S8). This evidence concerns the gene MRC1 and breast cancer.